Folgen
Heiner Wedemeyer
Heiner Wedemeyer
Dept. of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
Bestätigte E-Mail-Adresse bei mh-hannover.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
17982017
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis
AJ van der Meer, BJ Veldt, JJ Feld, H Wedemeyer, JF Dufour, F Lammert, ...
Jama 308 (24), 2584-2593, 2012
17592012
EASL recommendations on treatment of hepatitis C 2018
European Association for The Study of The Liver
Journal of hepatology 69 (2), 461-511, 2018
1697*2018
EASL Clinical Practice Guidelines: management of hepatitis C virus infection
European Association For The Study Of The Liver
Journal of hepatology 55 (2), 245-264, 2011
15022011
ABT-450/r–ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis
F Poordad, C Hezode, R Trinh, KV Kowdley, S Zeuzem, K Agarwal, ...
New England Journal of Medicine 370 (21), 1973-1982, 2014
11472014
Treatment of acute hepatitis C with interferon alfa-2b
E Jaeckel, M Cornberg, H Wedemeyer, T Santantonio, J Mayer, M Zankel, ...
New England Journal of Medicine 345 (20), 1452-1457, 2001
11322001
Treating viral hepatitis C: efficacy, side effects, and complications
MP Manns, H Wedemeyer, M Cornberg
Gut 55 (9), 1350-1359, 2006
8992006
Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma
LA Ormandy, T Hillemann, H Wedemeyer, MP Manns, TF Greten, ...
Cancer research 65 (6), 2457-2464, 2005
8622005
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis
BJ Veldt, EJ Heathcote, H Wedemeyer, J Reichen, WP Hofmann, ...
Annals of internal medicine 147 (10), 677-684, 2007
8392007
Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection
H Wedemeyer, XS He, M Nascimbeni, AR Davis, HB Greenberg, ...
The Journal of Immunology 169 (6), 3447-3458, 2002
7982002
Retreatment of HCV with ABT-450/r–ombitasvir and dasabuvir with ribavirin
S Zeuzem, IM Jacobson, T Baykal, RT Marinho, F Poordad, M Bourlière, ...
New England Journal of Medicine 370 (17), 1604-1614, 2014
7632014
Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
B Hoechst, T Voigtlaender, L Ormandy, J Gamrekelashvili, F Zhao, ...
Hepatology 50 (3), 799-807, 2009
6172009
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
AG Duffy, SV Ulahannan, O Makorova-Rusher, O Rahma, H Wedemeyer, ...
Journal of hepatology 66 (3), 545-551, 2017
6052017
Hepatitis delta virus
SA Hughes, H Wedemeyer, PM Harrison
The Lancet 378 (9785), 73-85, 2011
5932011
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective
J Jaroszewicz, BC Serrano, K Wursthorn, K Deterding, J Schlue, ...
Journal of hepatology 52 (4), 514-522, 2010
5682010
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
5292014
Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers
XS He, B Rehermann, FX López-Labrador, J Boisvert, R Cheung, ...
Proceedings of the National Academy of Sciences 96 (10), 5692-5697, 1999
5021999
Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead
H Wedemeyer, MP Manns
Nature reviews Gastroenterology & hepatology 7 (1), 31-40, 2010
4532010
Peginterferon plus adefovir versus either drug alone for hepatitis delta
H Wedemeyer, C Yurdaydìn, GN Dalekos, A Erhardt, Y Çakaloğlu, ...
New England Journal of Medicine 364 (4), 322-331, 2011
4472011
Long‐term efficacy of tenofovir monotherapy for hepatitis B virus‐monoinfected patients after failure of nucleoside/nucleotide analogues
F van Bömmel, RA de Man, H Wedemeyer, K Deterding, J Petersen, ...
Hepatology 51 (1), 73-80, 2010
4252010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20